[go: up one dir, main page]

IT1251615B - ANTIELASTASIC ACTIVITY MEDICATION. - Google Patents

ANTIELASTASIC ACTIVITY MEDICATION.

Info

Publication number
IT1251615B
IT1251615B ITMI912652A ITMI912652A IT1251615B IT 1251615 B IT1251615 B IT 1251615B IT MI912652 A ITMI912652 A IT MI912652A IT MI912652 A ITMI912652 A IT MI912652A IT 1251615 B IT1251615 B IT 1251615B
Authority
IT
Italy
Prior art keywords
antielastasic
medication
activity
activity medication
preparation
Prior art date
Application number
ITMI912652A
Other languages
Italian (it)
Inventor
Gerardo Bernasconi
Original Assignee
Golgi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golgi Sa filed Critical Golgi Sa
Priority to ITMI912652A priority Critical patent/IT1251615B/en
Publication of ITMI912652A0 publication Critical patent/ITMI912652A0/en
Priority to EP92920465A priority patent/EP0565658A1/en
Priority to CA002097611A priority patent/CA2097611A1/en
Priority to JP5506603A priority patent/JPH06506500A/en
Priority to PCT/EP1992/002269 priority patent/WO1993006823A1/en
Priority to AU26644/92A priority patent/AU2664492A/en
Publication of ITMI912652A1 publication Critical patent/ITMI912652A1/en
Application granted granted Critical
Publication of IT1251615B publication Critical patent/IT1251615B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Si descrive l'uso di un derivato terpenico per la preparazione di un medicamento utile nel trattamento dell'enfisema polmonare.The use of a terpene derivative for the preparation of a medicament useful in the treatment of pulmonary emphysema is described.

ITMI912652A 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION. IT1251615B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.
EP92920465A EP0565658A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
CA002097611A CA2097611A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase actibity, against pulmonary emphysema
JP5506603A JPH06506500A (en) 1991-10-04 1992-09-30 Verbenone with anti-elastase activity against emphysema
PCT/EP1992/002269 WO1993006823A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
AU26644/92A AU2664492A (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.

Publications (3)

Publication Number Publication Date
ITMI912652A0 ITMI912652A0 (en) 1991-10-04
ITMI912652A1 ITMI912652A1 (en) 1993-04-04
IT1251615B true IT1251615B (en) 1995-05-17

Family

ID=11360822

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.

Country Status (6)

Country Link
EP (1) EP0565658A1 (en)
JP (1) JPH06506500A (en)
AU (1) AU2664492A (en)
CA (1) CA2097611A1 (en)
IT (1) IT1251615B (en)
WO (1) WO1993006823A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
PT2857007T (en) 2012-06-05 2018-06-25 Univ Korea Res & Bus Found Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
CN113603802B (en) * 2021-08-24 2022-10-14 华侨大学 Preparation method and application of verbena polysaccharide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH625197A5 (en) * 1976-06-03 1981-09-15 Buskine Sa Process for preparing verbenone, myrtenal and pinocarveol
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions

Also Published As

Publication number Publication date
CA2097611A1 (en) 1993-04-04
JPH06506500A (en) 1994-07-21
EP0565658A1 (en) 1993-10-20
ITMI912652A0 (en) 1991-10-04
AU2664492A (en) 1993-05-03
ITMI912652A1 (en) 1993-04-04
WO1993006823A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AR042262A2 (en) USE OF 8,9-DIHYDROESTRONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS
IT1240360B (en) USE OF AN ALPHA-HYDROXIVITAMIN D DERIVATIVE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF HYPERPARATIROIDISM
AR038429A2 (en) MARCFORTINA 15-RENT-16-HYDROXYL COMPOUNDS
DE69331409D1 (en) ORAL 1ALPHA HYDROXYPREVITAMIN D
NO954694L (en) Dosage form for antidepressants
IT9022471A0 (en) PROCEDURE AND EQUIPMENT FOR THE UNIQUE COMBINATION OF DRUGS CORRESPONDING TO A THERAPY DESCRIBED FOR A SPECIFIC PATIENT
ATE152172T1 (en) PREPARATION OF A RECOMBINANT HUMAN INTERLEUKIN-1 INHIBITOR
DE68901043D1 (en) AQUEOUS PHARMACEUTICAL PREPARATION.
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
BR9509975A (en) Pharmaceutical formulation
ES2062137T3 (en) USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.
DK0736029T3 (en) Anticonvulsant pseudofructopyranose sulfamates
ES2063186T3 (en) DERIVATIVES FTALINIDA, PHARMACEUTICAL COMPOSITION AND USE.
IT1251838B (en) USE OF NIMESULIDE IN THE TREATMENT OF CATARACT
SE8204873D0 (en) PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE
FI955837A0 (en) A process for preparing an oral solid dosage form containing diclofenac
FI934680A0 (en) ARYLMORFOLIN, FRAMSTAELLNING OCH ANVAENDING
DK0561846T3 (en) 4,5-dihydroxy and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethanes having therapeutic effect
ES2105605T3 (en) TAQUIQUININE ANTAGONISTS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS.
IT1251615B (en) ANTIELASTASIC ACTIVITY MEDICATION.
HUP9801686A2 (en) Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases
ES2094757T3 (en) A MEGACARIOCITOPOYETIC FACTOR.
IT1252659B (en) PROCEDURE FOR THE PURIFICATION OF 1,1,1-TRIFLUORO-2-FLUOROETANO AND 1,1,1-TRIFLUORO-2,2-DICHLOROETANO
FI860098A0 (en) NYA PIPERAZINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION SOM INNEHAOLLER DESSA FOERENINGAR SOM AKTIV INGREDIENS.
FI934468A0 (en) BENSENBORSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM SYTESMELLANPRODUKTER

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029